Updated Results of a Phase II Study of Reduced-Intensity Chemotherapy with Mini-Hyper-CVD in Combination with Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Nicholas J. Short, Hagop M. Kantarjian, Farhad Ravandi, Xuelin Huang, Nitin Jain, Koji Sasaki, Rita Khouri, Naval G. Daver, Naveen Pemmaraju, Joseph D. Khoury, Jeffrey L. Jorgensen, Yesid Alvarado, Marina Y Konopleva, Guillermo Garcia-Manero, Tapan M. Kadia, Musa E. Yilmaz, Gautam M. Borthakur, Jan A. Burger, Steven M. Kornblau, William G. Wierda, Courtney D. DiNardo, Alessandra Ferrajoli, Jovitta Jacob, Meagan Rostykus, Rebecca Garris, Marygrace Ward, Binru Huang, Corabelle Encarnacion, Christopher Loiselle, Susan M. O'Brien, Elias Jabbour
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2986209396